IPO registrations (S-1, F-1) · Registrants

MDxHealth SA

SEC CIK
1872529 · filings on EDGAR ↗
Registration
Form F-1, first filed 2021-10-13, last 2021-11-01; 1 initial registration, 2 amendments
Outcome
Final prospectus filed 2021-11-05; declared effective 2021-11-03
Industry (SIC)
Services-Medical Laboratories 8071
Incorporated in
C9
Business address
CAP BUSINESS CENTER, RUE D'ABHOOZ, 31, B-4040, Herstal, C9 00000
Ticker
MDXH (Nasdaq)
EDGAR entity type
other
Insiders and CEO pay
MDxHealth SA on the corporate pages

Offering terms

Final price
$12.00 per ADS (424B4 filed 2021-11-05, an initial public offering)
Shares sold
3,750,000
Gross proceeds
$45,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol MDXH
Lead underwriters
Piper Sandler
Syndicate
BTIG; Oppenheimer; KBC Securities USA

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 6

FiledFormWhat it isName as filedEDGAR
2021-10-13F-1F-1 (foreign registration)MDxHealth SA0001213900-21-052578 ↗
2021-10-28F-1/AF-1/A (amendment)MDxHealth SA0001213900-21-054912 ↗
2021-11-01F-1/AF-1/A (amendment)MDxHealth SA0001213900-21-055831 ↗
2021-11-03EFFECTEFFECT (declared effective)MDxHealth SA9999999995-21-004176 ↗
2021-11-05424B4424B4 (final prospectus)MDxHealth SA0001213900-21-057043 ↗
2022-12-30EFFECTEFFECT (declared effective)MDxHealth SA9999999995-23-000009 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2021-11-01F-1/Aregistration statement9,989,881-0primary document; shares headlinedocument ↗
2021-11-05424B4final prospectus$12.003,750,000$45,000,000Nasdaq MDXH4primary document; price sentence, shares headline, proceeds table, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
MVM Partners LLPTenPercentOwner12021
MVM Partners, LLCDirector; TenPercentOwner32023–2026
Holder MichaelDirector22026
Hoffman KoenDirector22026
Siegel Sanford JayDirector22026
Windels HildeDirector22026
HARDISON DON MDirector22026
Bednarski EricDirector22026
Bellano JohnOfficerChief Commercial Officer22026
KALFUS RONOfficerChief Financial Officer12026
McGarrity MichaelDirector,OfficerChief Executive Officer22026
Sollee JosephOfficerSee Remarks22026
OConnell BrendanOfficerVP, Finance and Accounting22026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2022-08-15MDxHealth SAOther Health CareIndefinite$5,000,00011

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerMDxHealth SAForm D private offeringsCIK (EXACT)
SEC filerMDxHealth SASEC filers (EDGAR)CIK (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Services-Medical Laboratories, C9 first:

More with this interest.

In other datasets, the same topic (Health) in C9:

Interests: Services-Medical Laboratories · Health